Geovax appoints dr. marc pipas as executive medical director, oncology

Strengthening geovax's team advancing gedeptin® clinical program atlanta, ga, jan. 08, 2024 (globe newswire) -- via newmediawire – geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the appointment of j. marc pipas, m.d.
GOVX Ratings Summary
GOVX Quant Ranking